CoChat

Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 4 of the 13 sources its claims cite were checked for support.

Abstract

AIMS: Neointimal hyperplasia (NIH) characterized by vascular smooth muscle cell (VSMC) dysfunctions plays a critical role in many vascular diseases including atherosclerosis and restenosis, which leads to serious ischaemic complications and has limited therapeutic approaches. Our previous studies confirm a critical role for nuclear factor erythroid 2-related factor 3 (Nrf3) in VSMC differentiation. However, little is known about the functional implications of Nrf3 in NIH. METHODS AND RESULTS: Transcriptome dataset and human atherosclerotic samples were used to determine Nrf3 expression levels. Global (Nrf3-/-) and VSMC-specific (Nrf3ΔSMC) Nrf3 knockout mice were used to assess the role of Nrf3 in VSMC function and injury-induced NIH. Complementary molecular methods were performed to identify Nrf3 downstream targets and elucidate the regulatory role of Nrf3 in target gene regulation. Porcine carotid stenting model was used to validate the therapeutic effects of Nrf3 inhibition in vascular remodelling. Transcriptomic data and immunostaining analysis showed increased levels of Nrf3, and a positive correlation between Nrf3 and NIH in the human atherosclerotic vessels. Various pathophysiological stimuli induced endoplasmic reticulum stress that enhanced Nrf3 expression via Activating Transcription Factor 4 (ATF4). Nrf3 overexpression promoted both human and mouse VSMC proliferation, migration, and inflammatory response, while opposite effects were observed when Nrf3 was deleted or knockdown. Nrf3-/- and Nrf3ΔSMC mice showed decreased VSMC accumulation and attenuated vascular injury-induced NIH. Mechanistically, tripartite motif-containing 5 (Trim5), a genetic risk locus for coronary artery disease, was identified as a functional downstream target of Nrf3 in VSMCs and in injured arteries. Nrf3 enhanced autophagy in VSMCs and injured arteries by up-regulating Trim5 expression, which subsequently promoted dysfunctions of VSMCs, thereby increasing injury-induced NIH. Importantly, restoring either Nrf3 or Trim5 expression in Nrf3-/- mice rescued the arterial phenotypes observed in Nrf3-/- mice. Critically, the porcine carotid artery restenosis induced by ballooning and stenting was significantly reduced by suppressing Nrf3 expression through perivascular administration of the Nrf3 inhibitors. CONCLUSIONS: We comprehensively demonstrate that Nrf3 is a novel modulator in VSMC dysfunctions and injury-induced NIH. Nrf3 exerts its pathological functions by transcriptional activation of Trim5 gene, which in turn triggers autophagy in VSMCs and injured arteries, promoting arterial remodelling. Inhibiting the Nrf3-Trim5 signal axis ameliorates injury-induced NIH, offering novel therapeutics for treating patients with NIH-related vascular diseases.

Overview

CoChat Summary

TL;DR

Nrf3 is upregulated in human atherosclerotic lesions and injury-induced neointima, where ER stress/ATF4 induces its expression; Nrf3 transcriptionally activates Trim5, which binds BECN1 to promote autophagy and VSMC proliferation, migration, and inflammation. Genetic deletion or AAV9-mediated inhibition of Nrf3 reduces neointimal hyperplasia in mouse injury models and stent-induced restenosis in pigs, implicating the Nrf3–Trim5 axis as a therapeutic target.

Key findings

  • Nrf3 expression was significantly higher in human carotid, femoral, and infra-popliteal atherosclerotic lesions versus normal arteries in GSE100927; in 30 diseased femoral arterial (DFA) and 30 healthy femoral arterial (HFA) specimens, Nrf3 was abundant in the VSMC-rich neointimal region and positively associated with enlarged neointima area and higher neointima/media ratio.
  • Pathophysiological stimuli (FBS, PDGF-BB, TNF-α, ox-LDL) increased Nrf3 transcript/protein in mouse and human VSMCs; ER stress marker Grp78 increased, ATF4 silencing decreased Nrf3, and ChIP plus luciferase assays confirmed ATF4 binding to the Nrf3 promoter.
  • Nrf3 overexpression promoted VSMC proliferation, migration, and inflammatory response, while Nrf3 deletion/knockdown reduced these. In wire injury, Nrf3−/− and Nrf3ΔSMC mice had decreased neointimal area (0.011 ± 0.001 mm² in Nrf3−/− vs. 0.011 ± 0.001 mm² in Nrf3ΔSMC vs. 0.016 ± 0.001 mm² in WT) and neointima/media ratio (0.96 ± 0.12 vs. 1.02 ± 0.08 vs. 1.47 ± 0.19); AAV9-Nrf3 restoration increased neointimal area (0.016 ± 0.001 vs. 0.010 ± 0.001 mm²) and ratio (1.47 ± 0.18 vs. 0.93 ± 0.10).
  • Trim5 was downregulated in Nrf3−/− arteries; Nrf3 directly bound the Trim5 promoter and increased Trim5 expression. Nrf3–Trim5 promoted autophagy (BECN1/LC3B, autophagosomes/autolysosomes, autophagic flux), and Trim5 knockdown abolished Nrf3 effects. Restoring Trim5 in Nrf3−/− mice rescued injury-induced neointima area and ratio. In porcine carotid stenting, perivascular AAV9-shNrf3 reduced Nrf3, Trim5, LC3B, CD68+, Ki67+, neointima area, and neointima/media ratio versus AAV9-Scr.

Methods

  • Human data: GSE100927 transcriptomic dataset, GWAS Catalog GCST90132314, and 30 DFA plus 30 HFA specimens; ethical approval from the First Affiliated Hospital of Zhejiang University School of Medicine.
  • Mouse experiments: global Nrf3−/− and VSMC-specific Nrf3ΔSMC mice generated from Nrf3flox/flox; femoral artery wire injury and carotid artery ligation; AAV9-Nrf3 or AAV9-Trim5 rescue; RNA-seq analyzed with DESeq2; histology, immunofluorescence, FISH; primary mouse aortic VSMCs (P5–P8) and human VSMC line; ChIP, luciferase reporter, co-immunoprecipitation, transmission electron microscopy, and Cyto-ID autophagy assays.
  • Porcine experiments: Chinese domestic pigs (40–60 kg) with bare metal stent implantation into external carotid arteries; digital subtraction angiography every 30 days and histology at Day 90; perivascular AAV9-shNrf3 versus AAV9-Scr. Statistics: means ± S.E.M.; two-tailed Student’s t-test, one-way ANOVA with Bonferroni or Tamhane’s T2, Mann–Whitney, or Kruskal–Wallis with Dunn’s test; P < 0.05; SPSS version 19.0.

Limitations

  • Stated: only male mice were used because of hormonal fluctuations in female mice during the oestrous cycle; this limits broader implication and clinical translation, and future validation in females is needed.
  • Stated: the AAV9 CMV promoter caused Nrf3 overexpression in other tissues, particularly liver, indicating potential off-target effects; future studies should use more tissue-targeted promoters such as smooth muscle-specific promoters.
  • Stated: further investigation is needed into Nrf3 in lipid-driven atherosclerotic plaque development/progression, other signalling pathways that may regulate Nrf3, and the role of the PERK-ATF4 pathway in vascular remodelling.
  • Evident from the text (not framed as limitations by the authors): human validation used 30 DFA and 30 HFA specimens plus public datasets; mouse experiments used only male mice; the porcine study reports a 90-day endpoint.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/cvr/cvaf084

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical Abstract
Graphical Abstract CC BY-NC · PubMed Central
Figure 1 Expression profiles of Nrf3 in the healthy and diseased human arteries. (A–H) Transcriptome data of human control (Ctrl) and atherosclerotic (AS) peripheral arteries from carotid (CA), femoral (FA), and infra-popliteal (IPA) territories were downloaded from the Gene Expression Omnibus database (GEO, GSE100927, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE100927, contributed by Steenman et al.18) and analysed for Nrf3 and other gene expressions. The dataset includes total RNA extracted from 31 healthy arteries (10 Ctrl-CA, 11 Ctrl-FA, and 10 Ctrl-IPA) and 65 atherosclerotic arteries (27 AS-CA, 25 AS-FA, and 13 AS-IPA). (A) Dot plots of Nrf3 expression in GSE100927. (B) Heat maps of genes between AS peripheral arteries and corresponding controls; (C–E) GSEA analysis; (F–H) relationship between Nrf3 and MYH11 in carotid, femoral, and iliac popliteal arteries. (I–L) Healthy femoral artery specimens (HFA, n = 30) from patients without peripheral arterial diseases and diseased femoral artery specimens (DFA, n = 30) from patients with peripheral arterial diseases were collected and subjected to immunohistochemical staining. (I) Representative images of Nrf3 expression in human HFA and DFA, scale bars: 400 μm (left) and 100 μm (right) in the magnification images. (J) Dot plot of the average optical density and percentage of Nrf3 positive staining across different groups. (K and L) Spearman’s rank correlation analyses were carried out to characterize the relationships between the gene expression levels of Nrf3 with neointima area (mm2) and neointima/media ratio. X-axis represents expression level of Nrf3 (average optical density); Y-axis represents the neointima area (mm2) and neointima/media ratio. The solid line indicates the fitted linear regression line. (M) Representative immunofluorescence images of Nrf3 expression in human HFA and DFA, scale bars: 50 μm. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (A, J). ***P < 0.0001, *P < 0.05.
Figure 1 Expression profiles of Nrf3 in the healthy and diseased human arteries. (A–H) Transcriptome data of human control (Ctrl) and atherosclerotic (AS) peripheral arteries from carotid (CA), femoral (FA), and infra-popliteal (IPA) territories were downloaded from the Gene Expression Omnibus database (GEO, GSE100927, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE100927, contributed by Steenman et al.18) and analysed for Nrf3 and other gene expressions. The dataset includes total RNA extracted from 31 healthy arteries (10 Ctrl-CA, 11 Ctrl-FA, and 10 Ctrl-IPA) and 65 atherosclerotic arteries (27 AS-CA, 25 AS-FA, and 13 AS-IPA). (A) Dot plots of Nrf3 expression in GSE100927. (B) Heat maps of genes between AS peripheral arteries and corresponding controls; (C–E) GSEA analysis; (F–H) relationship between Nrf3 and MYH11 in carotid, femoral, and iliac popliteal arteries. (I–L) Healthy femoral artery specimens (HFA, n = 30) from patients without peripheral arterial diseases and diseased femoral artery specimens (DFA, n = 30) from patients with peripheral arterial diseases were collected and subjected to immunohistochemical staining. (I) Representative images of Nrf3 expression in human HFA and DFA, scale bars: 400 μm (left) and 100 μm (right) in the magnification images. (J) Dot plot of the average optical density and percentage of Nrf3 positive staining across different groups. (K and L) Spearman’s rank correlation analyses were carried out to characterize the relationships between the gene expression levels of Nrf3 with neointima area (mm2) and neointima/media ratio. X-axis represents expression level of Nrf3 (average optical density); Y-axis represents the neointima area (mm2) and neointima/media ratio. The solid line indicates the fitted linear regression line. (M) Representative immunofluorescence images of Nrf3 expression in human HFA and DFA, scale bars: 50 μm. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (A, J). ***P < 0.0001, *P < 0.05.CC BY-NC · PubMed Central
Figure 2 Nrf3 regulates vascular smooth muscle cell proliferation, migration, and inflammation response. VSMCs isolated from control littermates (Nrf3f/f) and Nrf3−/− mice aorta between passages 3 and 8 were subjected to serum starvation for 24 h. Subsequently, cells were treated with vehicle control (0% FBS), serum (20% FBS), PDGF-BB (10 ng/mL), TNF-α (20 ng/mL), or ox-LDL (50 μg/mL), and analysed. (A and B) Cell proliferation analysis by cell counting (A) and BrdU incorporation assay (B) (n = 4). (C) Wound-healing assay with quantification of migration area (%) (n = 4). (D) Trans-well migration assay with quantification of the migrated cell numbers (n = 4). (E–G) RT–qPCR analysis showed ICAM-1 (E), IL-6 (F), and IL-12β (G) expression under the treatment of TNF-α between Nrf3−/− and control VSMCs at 48 h (n = 6). Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (A–D) or two-way ANOVA test (E–G). *P < 0.05; ‘ns’ denotes non-significant differences.
Figure 2 Nrf3 regulates vascular smooth muscle cell proliferation, migration, and inflammation response. VSMCs isolated from control littermates (Nrf3f/f) and Nrf3−/− mice aorta between passages 3 and 8 were subjected to serum starvation for 24 h. Subsequently, cells were treated with vehicle control (0% FBS), serum (20% FBS), PDGF-BB (10 ng/mL), TNF-α (20 ng/mL), or ox-LDL (50 μg/mL), and analysed. (A and B) Cell proliferation analysis by cell counting (A) and BrdU incorporation assay (B) (n = 4). (C) Wound-healing assay with quantification of migration area (%) (n = 4). (D) Trans-well migration assay with quantification of the migrated cell numbers (n = 4). (E–G) RT–qPCR analysis showed ICAM-1 (E), IL-6 (F), and IL-12β (G) expression under the treatment of TNF-α between Nrf3−/− and control VSMCs at 48 h (n = 6). Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (A–D) or two-way ANOVA test (E–G). *P < 0.05; ‘ns’ denotes non-significant differences.CC BY-NC · PubMed Central
Figure 3 Nrf3 promotes injury-induced neointimal hyperplasia. (A and B) Nrf3 expression was detected in uninjured (sham) and injured femoral arteries at Days 3, 7, 14, and 28 by RT–qPCR (A) and immunofluorescence (IF) staining (B). *P < 0.05 (vs. Sham). (C and D) HE staining analysis of neointima formation in control littermates (Nrf3f/f), Nrf3 global (Nrf3−/−), and VSMC-specific (Nrf3ΔSMC) knockout mice at four weeks post-injury (Nrf3f/f, n = 15; Nrf3−/−, n = 14; Nrf3ΔSMC, n = 14). Representative images (C) and statistical analyses of neointima area, media area, and neointima/media ratio (D) were presented. (E and F) Restoring Nrf3 expression in Nrf3−/− mice rescued the phenotypes observed in Nrf3−/− mice. Nrf3f/f or Nrf3−/− mice were randomly administrated with control (AAV9-Scr) or Nrf3 overexpressing (AAV9-Nrf3) vector. Three weeks later, mice were subjected to femoral arterial injury. Injured arteries were collected at four weeks post-injury and subjected to HE staining analysis (Nrf3f/f + AAV9-Scr, n = 15; Nrf3−/−+AAV9-Scr, n = 15; Nrf3−/−+AAV9-Nrf3, n = 15). Representative images (E) and statistical analyses (F) were presented. (G and H) IF staining analysis with α-SMA antibody to quantify smooth muscle area in post-injury arteries of different groups (Nrf3f/f, n = 6; Nrf3−/−, n = 6; Nrf3ΔSMC, n = 6; Nrf3−/−+AAV9-Nrf3, n = 6). Representative images (G) and statistical analyses (H) were showed. (I) RT–qPCR analysis showed IL-6, IL-12β, and ICAM-1 expression at Day 7 after femoral injury (Nrf3f/f, n = 9; Nrf3−/−, n = 6; Nrf3ΔSMC, n = 7). Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by one-way ANOVA test (A, D, F, H, I). *P < 0.05; ‘ns’ denotes non-significant differences.
Figure 3 Nrf3 promotes injury-induced neointimal hyperplasia. (A and B) Nrf3 expression was detected in uninjured (sham) and injured femoral arteries at Days 3, 7, 14, and 28 by RT–qPCR (A) and immunofluorescence (IF) staining (B). *P < 0.05 (vs. Sham). (C and D) HE staining analysis of neointima formation in control littermates (Nrf3f/f), Nrf3 global (Nrf3−/−), and VSMC-specific (Nrf3ΔSMC) knockout mice at four weeks post-injury (Nrf3f/f, n = 15; Nrf3−/−, n = 14; Nrf3ΔSMC, n = 14). Representative images (C) and statistical analyses of neointima area, media area, and neointima/media ratio (D) were presented. (E and F) Restoring Nrf3 expression in Nrf3−/− mice rescued the phenotypes observed in Nrf3−/− mice. Nrf3f/f or Nrf3−/− mice were randomly administrated with control (AAV9-Scr) or Nrf3 overexpressing (AAV9-Nrf3) vector. Three weeks later, mice were subjected to femoral arterial injury. Injured arteries were collected at four weeks post-injury and subjected to HE staining analysis (Nrf3f/f + AAV9-Scr, n = 15; Nrf3−/−+AAV9-Scr, n = 15; Nrf3−/−+AAV9-Nrf3, n = 15). Representative images (E) and statistical analyses (F) were presented. (G and H) IF staining analysis with α-SMA antibody to quantify smooth muscle area in post-injury arteries of different groups (Nrf3f/f, n = 6; Nrf3−/−, n = 6; Nrf3ΔSMC, n = 6; Nrf3−/−+AAV9-Nrf3, n = 6). Representative images (G) and statistical analyses (H) were showed. (I) RT–qPCR analysis showed IL-6, IL-12β, and ICAM-1 expression at Day 7 after femoral injury (Nrf3f/f, n = 9; Nrf3−/−, n = 6; Nrf3ΔSMC, n = 7). Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by one-way ANOVA test (A, D, F, H, I). *P < 0.05; ‘ns’ denotes non-significant differences.CC BY-NC · PubMed Central
Figure 4 Trim5 is a transcription target gene of Nrf3 in injured arteries and VSMCs. (A and B) RNA-sequencing analysis of wire injured femoral artery at Day 7 between control littermates (Nrf3f/f) and Nrf3−/− mice (n = 3, each RNA sample was pooled from four injured femoral arteries). (A) Volcano plot showing differently regulated genes between Nrf3f/f and Nrf3−/− mice; (B) Trim5 expression levels (transcripts per kilobase million, TPM) between Nrf3f/f and Nrf3−/− mice in femoral artery injury (FAI) model and carotid artery ligation (CAL) model at Day 7. (C) The changes of Trim5 gene expression between Nrf3f/f and Nrf3 knockout mice (Nrf3−/− and Nrf3ΔSMC) were detected by RT–qPCR (n = 5–6). (D) Trim5 protein expression of Nrf3f/f and Nrf3ΔSMC mice was detected by immunofluorescence (scale bars: 100 μm), with quantification of the mean fluorescence intensity (n = 5–6). (E) RT–qPCR confirmed increased expression of Trim5 by Nrf3 overexpression (Ad-Nrf3) in VSMCs treated with PDGF-BB (10 ng/mL), TNF-α (20 ng/mL), ox-LDL (50 μg/mL), or vehicle control (n = 5). (F and G) RT–qPCR analyses for Trim5 expression in Nrf3f/f and Nrf3−/− VSMCs treated with PDGF-BB (10 ng/mL) or TNF-α (20 ng/mL) (n = 6). (H and I) Western blot analyses for Trim5 protein expression in VSMCs infected with control (Ad-Scr) or Nrf3 overexpressing (Ad-Nrf3) vector (H), or in Nrf3f/f and Nrf3−/− VSMCs (I), under treatment of PDGF-BB (10 ng/mL), TNF-α (20 ng/mL), and ox-LDL (50 μg/mL), respectively (n = 4). (J) Trim5 gene promoter reporter activity assays. Control (pSCR) or Nrf3 (pNrf3) plasmids were co-transfected with wild-type (WT) or mutated (Mut) Trim5 gene promoter reporter into VSMCs, as indicated. Cell lysates were subjected to luciferase activity assay (n = 6). (K) ChIP-qPCR assays for Trim5 gene promoter DNA enrichment by Nrf3. Cell lysates from VSMCs infected with Ad-flag-Nrf3 were subjected to immunoprecipitation using IgG or anti-Flag, and immunoprecipitated chromatin DNAs were subjected to qPCR analysis (n = 8). Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (B–E, H, I, K) or two-way ANOVA test (F, G, J). *P < 0.05.
Figure 4 Trim5 is a transcription target gene of Nrf3 in injured arteries and VSMCs. (A and B) RNA-sequencing analysis of wire injured femoral artery at Day 7 between control littermates (Nrf3f/f) and Nrf3−/− mice (n = 3, each RNA sample was pooled from four injured femoral arteries). (A) Volcano plot showing differently regulated genes between Nrf3f/f and Nrf3−/− mice; (B) Trim5 expression levels (transcripts per kilobase million, TPM) between Nrf3f/f and Nrf3−/− mice in femoral artery injury (FAI) model and carotid artery ligation (CAL) model at Day 7. (C) The changes of Trim5 gene expression between Nrf3f/f and Nrf3 knockout mice (Nrf3−/− and Nrf3ΔSMC) were detected by RT–qPCR (n = 5–6). (D) Trim5 protein expression of Nrf3f/f and Nrf3ΔSMC mice was detected by immunofluorescence (scale bars: 100 μm), with quantification of the mean fluorescence intensity (n = 5–6). (E) RT–qPCR confirmed increased expression of Trim5 by Nrf3 overexpression (Ad-Nrf3) in VSMCs treated with PDGF-BB (10 ng/mL), TNF-α (20 ng/mL), ox-LDL (50 μg/mL), or vehicle control (n = 5). (F and G) RT–qPCR analyses for Trim5 expression in Nrf3f/f and Nrf3−/− VSMCs treated with PDGF-BB (10 ng/mL) or TNF-α (20 ng/mL) (n = 6). (H and I) Western blot analyses for Trim5 protein expression in VSMCs infected with control (Ad-Scr) or Nrf3 overexpressing (Ad-Nrf3) vector (H), or in Nrf3f/f and Nrf3−/− VSMCs (I), under treatment of PDGF-BB (10 ng/mL), TNF-α (20 ng/mL), and ox-LDL (50 μg/mL), respectively (n = 4). (J) Trim5 gene promoter reporter activity assays. Control (pSCR) or Nrf3 (pNrf3) plasmids were co-transfected with wild-type (WT) or mutated (Mut) Trim5 gene promoter reporter into VSMCs, as indicated. Cell lysates were subjected to luciferase activity assay (n = 6). (K) ChIP-qPCR assays for Trim5 gene promoter DNA enrichment by Nrf3. Cell lysates from VSMCs infected with Ad-flag-Nrf3 were subjected to immunoprecipitation using IgG or anti-Flag, and immunoprecipitated chromatin DNAs were subjected to qPCR analysis (n = 8). Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (B–E, H, I, K) or two-way ANOVA test (F, G, J). *P < 0.05.CC BY-NC · PubMed Central
Figure 5 Nrf3 modulates VSMC functions through Trim5-mediated autophagy. (A–E) VSMCs were co-transfected with non-targeting control (Si-NT) or Trim5-specific (Si-Trim5) siRNAs and control (Ad-Scr) or Nrf3 overexpression (Ad-Nrf3) vectors as indicated. After 24 h of serum starvation, cells were treated with PDGF-BB (10 ng/mL) for 24 h, followed by RT–qPCR (A), EdU (B), CCK8 (C), trans-well migration (D), and western blot (E) assays, respectively (n = 4–6). (F) VSMCs were co-transfected with Ad-GFP-mCherry-LC3B, Si-Trim5, and Ad-Nrf3 (or their respective negative control: si-NT or Ad-Scr) as indicated, and treated with PDGF-BB (10 ng/mL). Cells were fixed and stained with DAPI, followed by confocal microscopy analysis. Representative images (left) (scale bars: 10 μm) and statistical analyses of autophagosome (AP) and autolysosome (ASS) numbers per cell (right) were presented (n = 6). (G) Transmission electron microscope (TEM) analysis of AP and ASS numbers in VSMCs. Representative images (left) [scale bars: 5 μm (up) and 1 μm (down)] and statistical analyses of AP/ASS number per cell (right) were showed (n = 6–8). (H) Cyto-ID Green and Hoechst were used for staining and detecting autophagy vesicles in live cells. Representative images (left) (scale bars: 50 μm) and statistical analyses of mean fluorescence intensity (MFI) over DAPI (right) were presented (n = 6). (I) Protein-dock analysis to predict the structure of TRIM5–BECN1 protein complex and their potential binding site. (J) Co-immunoprecipitation (Co-IP) assays. VSMCs were infected with Ad-Trim5-flag for 48 h, and subsequently treated with PDGF-BB (10 ng/mL) for 24 h. Cell lysates were immunoprecipitated with IgG or anti-Flag, followed by western blot assay to detect the interaction between Trim5 and BECN1. ‘+’ indicates overexpression of Nrf3 or knockdown of Trim5, such as Ad-Nrf3 or Si-Trim5. ‘−’ represents the corresponding control, such as Ad-Scr or Si-NT. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by two-way ANOVA test (A–H). *P < 0.05; ‘ns’ denotes non-significant differences.
Figure 5 Nrf3 modulates VSMC functions through Trim5-mediated autophagy. (A–E) VSMCs were co-transfected with non-targeting control (Si-NT) or Trim5-specific (Si-Trim5) siRNAs and control (Ad-Scr) or Nrf3 overexpression (Ad-Nrf3) vectors as indicated. After 24 h of serum starvation, cells were treated with PDGF-BB (10 ng/mL) for 24 h, followed by RT–qPCR (A), EdU (B), CCK8 (C), trans-well migration (D), and western blot (E) assays, respectively (n = 4–6). (F) VSMCs were co-transfected with Ad-GFP-mCherry-LC3B, Si-Trim5, and Ad-Nrf3 (or their respective negative control: si-NT or Ad-Scr) as indicated, and treated with PDGF-BB (10 ng/mL). Cells were fixed and stained with DAPI, followed by confocal microscopy analysis. Representative images (left) (scale bars: 10 μm) and statistical analyses of autophagosome (AP) and autolysosome (ASS) numbers per cell (right) were presented (n = 6). (G) Transmission electron microscope (TEM) analysis of AP and ASS numbers in VSMCs. Representative images (left) [scale bars: 5 μm (up) and 1 μm (down)] and statistical analyses of AP/ASS number per cell (right) were showed (n = 6–8). (H) Cyto-ID Green and Hoechst were used for staining and detecting autophagy vesicles in live cells. Representative images (left) (scale bars: 50 μm) and statistical analyses of mean fluorescence intensity (MFI) over DAPI (right) were presented (n = 6). (I) Protein-dock analysis to predict the structure of TRIM5–BECN1 protein complex and their potential binding site. (J) Co-immunoprecipitation (Co-IP) assays. VSMCs were infected with Ad-Trim5-flag for 48 h, and subsequently treated with PDGF-BB (10 ng/mL) for 24 h. Cell lysates were immunoprecipitated with IgG or anti-Flag, followed by western blot assay to detect the interaction between Trim5 and BECN1. ‘+’ indicates overexpression of Nrf3 or knockdown of Trim5, such as Ad-Nrf3 or Si-Trim5. ‘−’ represents the corresponding control, such as Ad-Scr or Si-NT. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by two-way ANOVA test (A–H). *P < 0.05; ‘ns’ denotes non-significant differences.CC BY-NC · PubMed Central
Figure 6 Functional importance of Trim5-mediated autophagy in Nrf3-mediated injury-induced NIH. (A and B) Increased Trim5 expression in injured arteries as detected by RT–qPCR (A) and immunofluorescence (IF) staining (scale bars: 20 μm) (B) analysis, respectively (n = 5–7). (C and D) RT–qPCR (C) and IF staining (scale bars: 20 μm) (D) analysis showing decreased Trim5 expression in injured arteries of Nrf3−/− mice (scale bars: 50 μm) (n = 6–8). (E) IF staining analysis of Trim5 expression in control littermates (Nrf3f/f), Nrf3−/−+AAV9-Scr (control), and Nrf3−/−+AAV9-Nrf3 mice (scale bars: 20 μm) (n = 5). (F) IF staining analysis of LC3B expression in injured femoral arteries at Day 7 of Nrf3f/f and Nrf3−/− mice (scale bars: 50 μm) (n = 7). (G) Transmission electron microscope (TEM) analysis of autophagy (AP and ASS numbers) in sham (FA) or injured femoral arteries (FAI) of Nrf3f/f and Nrf3−/− mice [scale bars: 2 μm (left) and 1 μm (right)] (n = 6–8). (H and I) IF staining analysis of Ki67, CD68, and CD45 positive cells (%) in wire injured femoral arteries at Day 7 of Nrf3f/f and Nrf3−/− mice (scale bars: 50 μm) (n = 8). Data included in (B, D–I) are representative images (left) and statistical analyses of relative mean fluorescence intensity (MFI) of target protein(s) over DAPI (B, D–F), AP&ASS numbers (G), or cell percentage (%, H and I). (J) Restoring Trim5 in Nrf3−/− mice rescued the phenotypes observed in Nrf3−/− mice. Nrf3f/f or Nrf3−/− mice were randomly administrated with control (AAV9-Scr) or Trim5 overexpressing (AAV9-Trim5) vector as indicated. Three weeks later, mice were subjected to FAI procedures. Injured vessels were collected at four weeks post-injury and subjected to HE staining analysis (n = 9 mice per group). (K) Autophagy inhibition reversed Nrf3-mediated NIH. Nrf3−/− mice were randomly injected with AAV9-Scr or AAV9-Nrf3. Three weeks later, mice were either subjected to sham or FAI procedures, followed by randomly administrated with vehicle control (sterile PBS) or chloroquine (CQ, 50 mg/kg, ip injection) on a daily basis. Four weeks after injury, vessels were collected and subjected to HE staining analysis (n = 6–7 mice per group). Data showed here are representative images (left) and statistical analyses of neointima area, media area, and ratio of neointima/media (right), respectively. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (A–D, F, H, I) or one-way ANOVA test (E, G, J, K). *P < 0.05; ‘ns’ denotes non-significant differences.
Figure 6 Functional importance of Trim5-mediated autophagy in Nrf3-mediated injury-induced NIH. (A and B) Increased Trim5 expression in injured arteries as detected by RT–qPCR (A) and immunofluorescence (IF) staining (scale bars: 20 μm) (B) analysis, respectively (n = 5–7). (C and D) RT–qPCR (C) and IF staining (scale bars: 20 μm) (D) analysis showing decreased Trim5 expression in injured arteries of Nrf3−/− mice (scale bars: 50 μm) (n = 6–8). (E) IF staining analysis of Trim5 expression in control littermates (Nrf3f/f), Nrf3−/−+AAV9-Scr (control), and Nrf3−/−+AAV9-Nrf3 mice (scale bars: 20 μm) (n = 5). (F) IF staining analysis of LC3B expression in injured femoral arteries at Day 7 of Nrf3f/f and Nrf3−/− mice (scale bars: 50 μm) (n = 7). (G) Transmission electron microscope (TEM) analysis of autophagy (AP and ASS numbers) in sham (FA) or injured femoral arteries (FAI) of Nrf3f/f and Nrf3−/− mice [scale bars: 2 μm (left) and 1 μm (right)] (n = 6–8). (H and I) IF staining analysis of Ki67, CD68, and CD45 positive cells (%) in wire injured femoral arteries at Day 7 of Nrf3f/f and Nrf3−/− mice (scale bars: 50 μm) (n = 8). Data included in (B, D–I) are representative images (left) and statistical analyses of relative mean fluorescence intensity (MFI) of target protein(s) over DAPI (B, D–F), AP&ASS numbers (G), or cell percentage (%, H and I). (J) Restoring Trim5 in Nrf3−/− mice rescued the phenotypes observed in Nrf3−/− mice. Nrf3f/f or Nrf3−/− mice were randomly administrated with control (AAV9-Scr) or Trim5 overexpressing (AAV9-Trim5) vector as indicated. Three weeks later, mice were subjected to FAI procedures. Injured vessels were collected at four weeks post-injury and subjected to HE staining analysis (n = 9 mice per group). (K) Autophagy inhibition reversed Nrf3-mediated NIH. Nrf3−/− mice were randomly injected with AAV9-Scr or AAV9-Nrf3. Three weeks later, mice were either subjected to sham or FAI procedures, followed by randomly administrated with vehicle control (sterile PBS) or chloroquine (CQ, 50 mg/kg, ip injection) on a daily basis. Four weeks after injury, vessels were collected and subjected to HE staining analysis (n = 6–7 mice per group). Data showed here are representative images (left) and statistical analyses of neointima area, media area, and ratio of neointima/media (right), respectively. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (A–D, F, H, I) or one-way ANOVA test (E, G, J, K). *P < 0.05; ‘ns’ denotes non-significant differences.CC BY-NC · PubMed Central
Figure 7 Nrf3 inhibition attenuates stenting-induced restenosis in a porcine model. (A) Experimental design of porcine model. The Chinese domestic porcine were administered daily with oral aspirin (100 mg daily dose) and clopidogrel (300 mg loading dose; 75 mg daily dose) 1 day before and after the procedure. The bare metal stent (BMS) was implanted into external carotid arteries under digital subtraction angiography (DSA). After stent implantation, control (AAV9-Scr) and Nrf3-specific shRNA (AAV9-shNrf3) vectors were randomly applied onto stented carotid arteries. Stented arteries were collected and subjected to RNA extraction and histology at Day 90. (B and C) HE (B) and Nrf3 immunofluorescence (IF) (C) staining analysis of the sham or stented arteries (n = 6–7). Data presented in (C) are representative IF images (left) (scale bars: 100 um) and statistical analyses of relative mean fluorescence intensity (MFI) of Nrf3 over DAPI (right). (D) Representative DSA angiography images showing in-stent restenosis (left) and quantitative analysis of the percentage (%) of restenosis with indicated treatments (n = 7). (E) Representative hard tissue sections showing in-stent restenosis (scale bars: 1 mm) (left) and statistical analyses of neointima area, media area, lumen area, and ratio of neointima/media (N/M), respectively (n = 7). (F) IF staining analysis and quantification of Trim5, LC3B, CD68, and Ki67 expression in stented external carotid arteries with indicated treatment at Day 90 post-stenting (n = 7). Representative IF images (left) (scale bars: 100 μm) and statistical analyses (right) of relative MFI over DAPI (Trim5 and LC3B), or cell percentage (% CD68+ and Ki67+) were presented. (G) The mRNA expression levels of Trim5, CD68, and PCNA were detected by RT–qPCR. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (C–G). *P < 0.05; ‘ns’ denotes non-significant differences.
Figure 7 Nrf3 inhibition attenuates stenting-induced restenosis in a porcine model. (A) Experimental design of porcine model. The Chinese domestic porcine were administered daily with oral aspirin (100 mg daily dose) and clopidogrel (300 mg loading dose; 75 mg daily dose) 1 day before and after the procedure. The bare metal stent (BMS) was implanted into external carotid arteries under digital subtraction angiography (DSA). After stent implantation, control (AAV9-Scr) and Nrf3-specific shRNA (AAV9-shNrf3) vectors were randomly applied onto stented carotid arteries. Stented arteries were collected and subjected to RNA extraction and histology at Day 90. (B and C) HE (B) and Nrf3 immunofluorescence (IF) (C) staining analysis of the sham or stented arteries (n = 6–7). Data presented in (C) are representative IF images (left) (scale bars: 100 um) and statistical analyses of relative mean fluorescence intensity (MFI) of Nrf3 over DAPI (right). (D) Representative DSA angiography images showing in-stent restenosis (left) and quantitative analysis of the percentage (%) of restenosis with indicated treatments (n = 7). (E) Representative hard tissue sections showing in-stent restenosis (scale bars: 1 mm) (left) and statistical analyses of neointima area, media area, lumen area, and ratio of neointima/media (N/M), respectively (n = 7). (F) IF staining analysis and quantification of Trim5, LC3B, CD68, and Ki67 expression in stented external carotid arteries with indicated treatment at Day 90 post-stenting (n = 7). Representative IF images (left) (scale bars: 100 μm) and statistical analyses (right) of relative MFI over DAPI (Trim5 and LC3B), or cell percentage (% CD68+ and Ki67+) were presented. (G) The mRNA expression levels of Trim5, CD68, and PCNA were detected by RT–qPCR. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (C–G). *P < 0.05; ‘ns’ denotes non-significant differences.CC BY-NC · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 7 Not checked · 134 Own results and interpretations

103 more claims

Create a free account to see all 144 claims and to verify the 9 references still open.

See all claims — free account
  • Probably not a substantial claim. 12
  • It may state two separate claims as one. 30

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 55 references

Cited by

See all 5

Metadata

Authors
Chen, Q., Sun, S., Shi, Z., Wang, L., Wang, Y., Zheng, A., Xu, X., Yang, M., Sun, K., Xiao, Q., & Zhang, L.
Affiliations
  • Queen Mary University of London (GB)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Xiao, Qingzhong
  • Zhang, Li
Venue
Cardiovascular Research
Published
2025-05-16
Volume
121
Issue
8
Pages
1282-1298
ISSN
  • 0008-6363 (ISSN-L)
  • 1755-3245
OpenAlex
W4410419044
Cited by
5
References
55
Citations by year
2026: 3 · 2025: 2
FWCI
1.50
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Key R&D Program of China (2022YFA1104200)
  • National Natural Sciences Foundation of China (82270430, 82125005, 82100503, 81930010)
  • Zhejiang Provincial Natural Science Foundation (LR20H020001)
  • Shanghai Natural Science Foundation (22ZR148000)
  • British Heart Foundation (PG/15/11/31279, PG/15/86/31723, PG/20/10458, PG/23/11371)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
Nrf3, TRIM5, intimal hyperplasia, vascular smooth muscle cells, restenosis, atherosclerosis, endoplasmic reticulum stress, ATF4, autophagy, vascular remodeling, carotid artery stenting, inflammation, knockout mice, transcriptomics
MeSH terms
Animals, Carotid Artery Diseases, Cells, Cultured, Disease Models, Animal, Humans, Hyperplasia, Male, Mice, Inbred C57BL, Muscle, Smooth, Vascular, Signal Transduction, Mice, Knockout, Carotid Artery Injuries, Myocytes, Smooth Muscle, Ubiquitin-Protein Ligases, Cell Proliferation, Mice, Neointima, Vascular Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia. https://app.cochat.ai/papers/10.1093/cvr/cvaf084
The paper
Chen, Q., Sun, S., Shi, Z., Wang, L., Wang, Y., Zheng, A., Xu, X., Yang, M., Sun, K., Xiao, Q., & Zhang, L. (2025). Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf084

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.